Davendra Sohal

10.6k total citations · 2 hit papers
167 papers, 3.5k citations indexed

About

Davendra Sohal is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Davendra Sohal has authored 167 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 109 papers in Oncology, 62 papers in Pulmonary and Respiratory Medicine and 58 papers in Cancer Research. Recurrent topics in Davendra Sohal's work include Pancreatic and Hepatic Oncology Research (70 papers), Cancer Genomics and Diagnostics (52 papers) and Renal cell carcinoma treatment (22 papers). Davendra Sohal is often cited by papers focused on Pancreatic and Hepatic Oncology Research (70 papers), Cancer Genomics and Diagnostics (52 papers) and Renal cell carcinoma treatment (22 papers). Davendra Sohal collaborates with scholars based in United States, United Kingdom and France. Davendra Sohal's co-authors include Alok A. Khorana, Philip A. Philip, Ramesh K. Ramanathan, Eileen M. O’Reilly, Daniel A. Laheru, Andrew M. Lowy, Andrea Wang‐Gillam, Katherine A. Guthrie, Muhammad Shaalan Beg and Andrew Hendifar and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Davendra Sohal

157 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial

2020 327 citations Michael J. Pishvaian, Edik M. Blais et al. profile →
Efficacy of Perioperative Chemotherapy for Resectable Pancreatic Adenocarcinoma

2021 175 citations Davendra Sohal, Syed A. Ahmad et al. profile →

Peers

Countries citing papers authored by Davendra Sohal

Since Specialization

Citations

This map shows the geographic impact of Davendra Sohal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Davendra Sohal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Davendra Sohal more than expected).

Fields of papers citing papers by Davendra Sohal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Davendra Sohal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Davendra Sohal. The network helps show where Davendra Sohal may publish in the future.

Co-authorship network of co-authors of Davendra Sohal

This figure shows the co-authorship network connecting the top 25 collaborators of Davendra Sohal. A scholar is included among the top collaborators of Davendra Sohal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Davendra Sohal. Davendra Sohal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Chemotherapy dose density is prognostic for overall survival in patients with resectable pancreas cancer: A landmark analysis of SWOG 1505 2025 ·Cancer ·Sameer H. Patel, (unknown), Davendra Sohal, Katherine A. Guthrie, Lisa A. Kachnic, E. Gabriela Chiorean, Andrew M. Lowy, Flavio G. Rocha, Howard S. Höchster, Philip A. Philip, Syed A. Ahmad	2
2	Intratumoral Cell Neighborhoods Coordinate Outcomes in Pancreatic Ductal Adenocarcinoma 2024 ·Gastroenterology ·Max M. Wattenberg, (unknown), Ignacio Garrido‐Laguna, (unknown), (unknown), (unknown), Jesse Lee, Kajsa E. Affolter, Sean J. Mulvihill, Muhammad Shaalan Beg, Andrea Wang‐Gillam, James L. Wade, Katherine A. Guthrie, E. Gabriela Chiorean, Syed A. Ahmad, Andrew M. Lowy, Philip Agop Philip, Davendra Sohal, Gregory L. Beatty	11
3	625P Initial results from the phase I, first-in-human study of the covalent, PI3Kα inhibitor TOS-358 in patients with solid tumors, expressing PI3Kα mutations or amplifications 2024 ·Annals of Oncology ·Marwan Fakih, Davendra Sohal, Justin Call, Susanna V. Ulahannan, (unknown), (unknown), Thomas B. Karasic, Alexander I. Spira, Min Zhong, (unknown), Kishore Hari, Ovidiu C. Trifan, (unknown)	2
4	An open-label, multicenter study investigating RP2 oncolytic immunotherapy in combination with second-line systemic atezolizumab combined with bevacizumab in patients with locally advanced unresectable or metastatic hepatocellular carcinoma. 2024 ·Journal of Clinical Oncology ·Kevin Kim, Anwaar Saeed, Davendra Sohal, Julien Edeline, Jeong Heo, (unknown), (unknown), Guy Ungerechts	2
5	A phase 1b study of NC410 in combination with pembrolizumab in immune checkpoint inhibitor (ICI) naïve, and refractory microsatellite stable (MSS)/microsatellite instability-low (MSI-L) colorectal cancer (CRC) and ovarian cancer. 2024 ·Journal of Clinical Oncology ·Eric S. Christenson, Daruka Mahadevan, Syed Mohammad Ali Kazmi, Sudhir Manda, Davendra Sohal, Thomas E. Hutson, Siqing Fu, (unknown), (unknown), Emilia Alina Barbu, Dallas B. Flies, Solomon Langermann, Michael Chisamore, Martin Gutierrez, Marc Matrana, (unknown), Raymond Wadlow, (unknown), (unknown), Dung T. Le	2
6	A phase 1, first-in-human study of autologous monocytes engineered to express an anti-HER2 chimeric antigen receptor (CAR) in participants with HER2-overexpressing solid tumors. 2024 ·Journal of Clinical Oncology ·Yara Abdou, Paula R. Pohlmann, Richard T. Maziarz, Hemant S. Murthy, Yuan Yuan, Anuradha Krishnamurthy, (unknown), (unknown), Daniel J. Blumenthal, Linara Gabitova, (unknown), Kenneth W. Locke, (unknown), Michael Klichinsky, Daniel Cushing, Thomas Condamine, Davendra Sohal	4
7	Phase I study of peposertib and avelumab with or without palliative radiotherapy in patients with advanced solid tumors 2024 ·ESMO Open ·Bradford A. Perez, Raid Aljumaily, Thomas U. Marron, Michael Shafique, Howard A. Burris, Wade T. Iams, Steven J. Chmura, Jason J. Luke, William J. Edenfield, Davendra Sohal, Xiaoyun Liao, Carsten Boesler, (unknown), (unknown), (unknown), (unknown), (unknown), Scott Antonia	10
8	Disparities in Clinical Trial Participation: A Cross-Sectional Survey of Cancer Patients at a Midwest Academic Medical Center 2024 ·Current Oncology ·(unknown), Melinda Butsch Kovacic, N. Shesh, Davendra Sohal	1
9	Analysis of the fecal metagenome in long‐term survivors of pancreas cancer 2023 ·Cancer ·Jordan Kharofa, David Haslam, (unknown), Allison Weiss, Sameer H. Patel, Kyle Wang, Hope Esslinger, Olugbenga Olowokure, Davendra Sohal, (unknown), Syed A. Ahmad, Senu Apewokin	14
10	738 A phase 1/2 study investigating the safety and efficacy of autologous TAC T cells in subjects with unresectable, locally advanced or metastatic claudin 18.2+ solid tumors 2023 ·SHILAP Revista de lepidopterología ·Daniel J. Olson, Ecaterina E. Dumbrava, (unknown), (unknown), Syma Iqbal, Davendra Sohal, Maria Apostolopoulou, (unknown), Deyaa Adib, Benjamin L. Schlechter	1
11	Mismatch Repair and Microsatellite Instability Testing for Immune Checkpoint Inhibitor Therapy: ASCO Endorsement of College of American Pathologists Guideline 2023 ·Journal of Clinical Oncology ·Praveen Vikas, Hans Messersmith, Carolyn C. Compton, Lynette M. Sholl, Russell R. Broaddus, Anjee Davis, Maria Del Pilar Estevez-Diz, Rohan Garje, Panagiotis A. Konstantinopoulos, Aliza Leiser, Anne M. Mills, Barbara M. Norquist, Michael J. Overman, Davendra Sohal, Richard Turkington, Tyler Johnson	57
12	An adaptive approach to neoadjuvant therapy to maximize resection rates for pancreatic adenocarcinoma: A phase II trial. 2023 ·Journal of Clinical Oncology ·Davendra Sohal, Jordan Kharofa, (unknown), (unknown), Sameer H. Patel, Gregory C. Wilson, Jonathan Sussman, (unknown), Krushna C. Patra, Vladimir Y. Bogdanov, Taylor S. Riall, Yana Zavros, Rachna T. Shroff, Syed A. Ahmad	1
13	Radiation therapy in borderline resectable pancreatic cancer: A review 2022 ·Surgery ·Kevin M. Turner, Aaron M. Delman, Jordan Kharofa, Milton T. Smith, Kyuran A. Choe, Olugbenga Olowokure, Gregory C. Wilson, Sameer H. Patel, Davendra Sohal, Syed A. Ahmad	4
14	Moving Beyond the Momentum: Innovative Approaches to Clinical Trial Implementation 2021 ·JCO Oncology Practice ·Cathy Eng, Emerson Y. Chen, Jane E. Rogers, Mark A. Lewis, Jonathan Strosberg, Ramya Thota, Smitha Krishnamurthi, Paul E. Oberstein, (unknown), Gary L. Buchschacher, Sandip Pravin Patel, Davendra Sohal, Taymeyah Al‐Toubah, Philip Philip, Arvind Dasari, (unknown), Stacey Stein	6
15	Ceralasertib-Mediated ATR Inhibition Combined With Olaparib in Advanced Cancers Harboring DNA Damage Response and Repair Alterations (Olaparib Combinations) 2021 ·JCO Precision Oncology ·Haider Mahdi, Navid Hafez, Deborah B. Doroshow, Davendra Sohal, (unknown), T. Khanh, Patricia LoRusso, Juliane M. Jürgensmeier, (unknown), Jeffrey Sklar, Colin P. Glover, Brunella Felicetti, Emma Dean, Peter G. Mortimer, Geoffrey I. Shapiro, Joseph P. Eder	56
16	Molecular Profiling of Patients with Pancreatic Cancer: Initial Results from the Know Your Tumor Initiative 2018 ·Clinical Cancer Research ·Michael J. Pishvaian, R Joseph Bender, (unknown), Lola Rahib, Andrew Hendifar, Sameh Mikhail, Vincent Chung, Vincent J. Picozzi, Davendra Sohal, Edik M. Blais, Kimberly Mason, Emily E. Lyons, Lynn M. Matrisian, Jonathan R. Brody, Subha Madhavan, Emanuel F. Petricoin	149
17	Adjuvant and neoadjuvant therapy for resectable pancreatic adenocarcinoma 2017 ·Chinese Clinical Oncology ·Davendra Sohal	7
18	Molecular characteristics of biliary tract cancer 2016 ·Critical Reviews in Oncology/Hematology ·Davendra Sohal, Shiva Shrotriya, Mohamed E. Abazeed, Michael Cruise, Alok A. Khorana	29
19	Methylome Profiling Reveals Distinct Alterations in Phenotypic and Mutational Subgroups of Myeloproliferative Neoplasms 2012 ·Cancer Research ·Sangeeta Nischal, Sanchari Bhattacharyya, Maximilian Christopeit, Yiting Yu, Li Zhou, Tushar D. Bhagat, Davendra Sohal, Britta Will, Yongkai Mo, Masako Suzuki, Animesh Pardanani, Michael A. McDevitt, Jaroslaw P. Maciejewski, Ari Melnick, John M. Greally, Ulrich Steidl, Alison R. Moliterno, Amit Verma	42
20	Transforming Growth Factor- β Signaling in Normal and Malignant Hematopoiesis 2007 ·Journal of Interferon & Cytokine Research ·Iris Isufi, Mahesh Seetharam, Li Zhou, Davendra Sohal, Joanna Opalinska, Perry Pahanish, Amit Verma	56

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact